argenx
Karl G. serves as the Chief Financial Officer at argenx since June 2021, bringing extensive experience from a long career at Pfizer, where roles spanned from Vice President Finance positions in oncology and specialty care to various finance leadership roles across Europe and North America. Prior to Pfizer, Karl G. worked at PwC, advancing from a Senior Manager to a seconded role as UK Treasury Manager at Pfizer. Karl G. holds an MBA from Henley Business School and a B Com from the University of Pretoria, complemented by Chartered Accountant qualifications from the University of South Africa.
This person is not in any teams
This person is not in any offices
argenx
31 followers
Argenx discovers, designs and develops innovative antibody therapeutics for its own pipeline of treatments for cancer and autoimmune diseases and for its partners. Harnessing our technology and know-how, we aim to meet the needs of patients by engineer...